1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine

1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine is a complex organic compound with a molecular formula of C24H23F2N3. This compound is commonly referred to as "FPyMM" and is a potent and selective agonist of the alpha7 nicotinic acetylcholine receptor. It has been extensively studied for its potential therapeutic applications, particularly in the treatment of cognitive disorders such as Alzheimer's disease. FPyMM is typically used in research settings to study the effects of alpha7 nicotinic acetylcholine receptor activation on various physiological and behavioral outcomes. It has been shown to improve cognitive function, enhance memory consolidation, and reduce anxiety-like behaviors in animal models. From a chemical perspective, FPyMM is a pyrrole derivative that contains two fluorophenyl substituents. The compound is highly lipophilic, meaning it is able to easily cross the blood-brain barrier and access the central nervous system. It is also metabolically stable, meaning it remains active in the body for an extended period of time. Overall, FPyMM is a promising compound with potential therapeutic applications in the treatment of cognitive disorders. Its unique chemical properties and selective receptor activation make it an important tool for researchers studying the effects of nicotinic acetylcholine receptor activation on brain function and behavior.